These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 16237469

  • 1. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A, Lozano Miranda A, Samalvides Cuba F, Antunez de Mayolo Ramis E.
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [Abstract] [Full Text] [Related]

  • 2. Significance of isolated hepatitis B core antibody in blood donors.
    Schifman RB, Rivers SL, Sampliner RE, Krammes JE.
    Arch Intern Med; 1993 Oct 11; 153(19):2261-6. PubMed ID: 8215729
    [Abstract] [Full Text] [Related]

  • 3. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct 11; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W, Muszyńska M, Pawłowska M.
    Med Sci Monit; 2002 Jul 11; 8(7):CR516-9. PubMed ID: 12118201
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum].
    Vrijmoeth P, Heijtink RA, Schreuder H, Kroes AC.
    Ned Tijdschr Geneeskd; 1997 Aug 30; 141(35):1694-7. PubMed ID: 9543786
    [Abstract] [Full Text] [Related]

  • 8. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 30; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 9. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun 30; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 10. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.
    J Gastroenterol Hepatol; 2008 Nov 30; 23(11):1710-5. PubMed ID: 18761556
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC.
    Int J Infect Dis; 2007 Sep 30; 11(5):394-401. PubMed ID: 17257877
    [Abstract] [Full Text] [Related]

  • 15. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L, Strong DM, Tegtmeier G, Stramer S.
    Transfusion; 2008 Nov 30; 48(11):2315-22. PubMed ID: 18647367
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ.
    Vaccine; 2007 Sep 28; 25(39-40):6958-64. PubMed ID: 17714836
    [Abstract] [Full Text] [Related]

  • 17. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, Twu SJ, Su IJ, Huang LM, Lee CY.
    Hepatology; 2004 Dec 28; 40(6):1415-20. PubMed ID: 15565627
    [Abstract] [Full Text] [Related]

  • 18. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L, Tvrdík J, Kabieszová L, Petrousová L, Orságová I, Hozáková L, Lochman I, Kloudová A, Valkovský I, Letocha P, Schwarzová S, Hladík M, Zjevíková A.
    Vnitr Lek; 2011 Oct 28; 57(10):808-14. PubMed ID: 22097688
    [Abstract] [Full Text] [Related]

  • 19. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list.
    Domínguez M, Bárcena R, García M, López-Sanroman A, Nuño J.
    Liver Transpl; 2000 Jul 28; 6(4):440-2. PubMed ID: 10915165
    [Abstract] [Full Text] [Related]

  • 20. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
    Zhang FM, Zhao QX, Han JH, Zhou QH, Wang MC, Miao W, Li R.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug 28; 24(8):697-9. PubMed ID: 14521791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.